Abolfazl Avan
Western University, Mashhad University of Medical Sciences, Academic Medical Center, University of Amsterdam, Amsterdam UMC Location University of Amsterdam, Tabriz University of Medical Sciences
Research areas: Medicine · Psychiatry and Mental health · Dementia and Cognitive Impairment Research · Cardiovascular Health and Risk Factors · Acute Ischemic Stroke Management
0000-0002-5537-6385
About
Abolfazl Avan, MD, PhD, is a Research Associate and Adjunct Research Professor at the University of Western Ontario in London, Ontario. He has developed a strong background in neuroepidemiology and neurovascular research, particularly in modifiable risk factors of stroke, ischemic heart disease, and dementia. He is a member of the American Academy of Neurology, Movement Disorder Society, and the Global Burden of Disease Study.
Employment
-
Western University Adjunct Research Professor2023 - Present
-
Western University Research Associate2023 - Present
-
Mashhad University of Medical Sciences Clinician2017 - 2022
-
Academic Medical Center Fellowship2015 - 2015
-
VU University Medical Center PhD student2013 - 2015
-
Birjand University of Medical Sciences ER Clinician2010 - 2011
Education
-
Academic Medical Center, University of Amsterdam MD, PhD2015 - 2015
-
Mashhad University of Medical Sciences MD Internship2007 - 2009
- 2001 - 2009
-
VU University Medical Center PhD? - 2015
Projects & Funding
-
Fellowship Award for the Alzheimer’s Association International Conference® 2022 Alzheimer's Association2022 - 2022
-
Fellowship Award for the Alzheimer’s Association International Conference 2021 Alzheimer's Association2021 - 2021
-
MDS Travel Grants International Parkinson and Movement Disorder Society2013 - 2013
-
Free Copper Prize TU Hoogenraad2012 - 2012
-
Scientific Honour Stichting De Kist van Beresteyn2009 - 2009
-
Medical Scholorship Ministery of Health, Treatment, and Medical Education2001 - 2009
Publications (25)
- Decreasing incidence of stroke, ischaemic heart disease and dementia in Norway, 1990–2019, a Global Burden of Disease study: an opportunity Save
- Global, regional, and national trends of dementia incidence and risk factors, 1990–2019: A Global Burden of Disease study Save
- The Role of Zinc in the Treatment of Wilson’s Disease Save
- Brain health: Key to health, productivity, and well‐being Save
- Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 Save
- A new definition of brain reserve Save
- From Dementia to Eumentia: A New Approach to Dementia Prevention Save
- Cerebral blood flow changes during aging process and in cognitive disorders: A review Save
- Stroke and dementia, leading causes of neurological disability and death, potential for prevention Save
- Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019 Save
- Zinc Therapy in Early Alzheimer’s Disease: Safety and Potential Therapeutic Efficacy Save
- Concomitant vascular and neurodegenerative pathologies double the risk of dementia Save
- Wilson's Disease Should Be Treated with Zinc rather than Trientine or Penicillamine Save
- Role of Akt signaling in resistance to DNA-targeted therapy Save
- Biomarker analysis in CLEOPATRA: Searching for a sensitive prognostic factor in breast cancer Save
- Gaps and hurdles deter against following stroke guidelines for thrombolytic therapy in Iran: Exploring the problem Save
- Pharmacogenomic modeling in pancreatic cancer-letter Save
- Platinum-induced neurotoxicity and preventive strategies: Past, present, and future Save
- Zinc and copper in Alzheimer's disease Save
- AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients Save